Teva Pharmaceutical Industries Launches Authorized Generic Of Victoza In United States
$TEVA
Biotechnology: Pharmaceutical Preparations
Health Care
- Generic Victoza® is the first-ever generic GLP-1 and supports increased demand for this category of therapies in the U.S. market.
- This launch adds to Teva's continued commitment to its complex generic medicine portfolio.
- Liraglutide injection is indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus and reduce the risk of cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.